Sobi’s Olezarsen Shows Promising Results for Treating Severe Hypertriglyceridemia A pivotal study of olezarsen presented at the AHA reveals significant benefits in treating severe hypertriglyceridemia, notably reducing acute pancreatitis events.

Sobi’s Olezarsen Shows Promising Results for Treating Severe Hypertriglyceridemia #Sweden #Stockholm #Sobi #Olezarsen #sHTG

Free 1-hr webinar - July 1 | 12 PM ET

Severe hypertriglyceridemia (sHTG) often flies under the radar.

Join Dr. Seth Baum + Dr. James Underberg to gain insights on diagnosing + managing #sHTG.

🔍Case Studies 💬Live Q&A

🆓 Register: nta.ampstream.io/nta1

#sHTG #CardioMetabolicHealth